Genetic diversity and molecular epidemiology of HIV transmission

Future Virology

Volumn 7, Issue 3, 2012, Pages 239-252

  Castro Nallar, Eduardo ^a   Crandall, Keith A ^a   Pérez Losada, Marcos ^b  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b CENTRO DE INVESTIGAÇÃO EM BIODIVERSIDADE E RECURSOS GENÉTICOS   (Portugal)

Author keywords

drug resistance; genetic diversity; HIV; phylodynamics; transmission; vaccines

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS CENTRAL VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; POLYVALENT MOSAIC VACCINE; PROTEOME; UNCLASSIFIED DRUG;

ANTIVIRAL RESISTANCE; DISEASE COURSE; GENE SEQUENCE; GENETIC VARIABILITY; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PHYLOGENOMICS; POPULATION STRUCTURE; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 84858392944     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.4     Document Type: Review

References (153)

1. Laikre L, Allendorf FW, Aroner LC etal. Neglect of genetic diversity in implementation of the convention on biological diversity. Conserv. Biol. 24(1), 86-88 (2010).
2. Tishkoff SA, Reed FA, Friedlaender FOR etal. The genetic structure and history of Africans and African Americans. Science 324(5930), 1035-1044 (2009).
3. De Oliveira T, Pybus O, Rambaut A etal. Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature 444(7121), 836-837 (2006).
4. Groeneveld L, Lenstra J, Eding H etal. Genetic diversity in farm animals -a review. Anim. Genet. 41(Suppl. 1), 6-31 (2010).
5. Agashe D, Falk J, Bolnick D. Effects of founding genetic variation on adaptation to a novel resource. Evolution 65(9), 2481-2491 (2011).
6. Merlo LM, Maley CC. The role of genetic diversity in cancer. J. Clin. Invest. 120(2), 401-403 (2010).
7. Fischer W, Ganusov V, Giorgi E etal. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS ONE 5(8), e12303 (2010). n Characterization of early HIV dynamics by ultra-deep sequencing, showing the reduction of genetic diversity at the point of transmission and the early diversification of transmitted viruses.
8. Ross LL, Weinberg WG, Dejesus E etal. Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients. AIDS Res. Hum. Retrov. 26(4), 407-417 (2010).
9. Carvajal-Rodriguez A, Posada D, Pérez-Losada M etal. Disease progression and evolution of the HIV-1 env gene in 24 infected infants. Infect. Genet. Evol. 8(2), 110-120 (2008).
10. Lemey P, Pond SLK, Drummond AJ etal. Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput. Biol. 3(2), 282-292 (2007).
11. Salemi M, Strimmer K, Hall WW etal. Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution. FASEB J. 15(2), 276-278 (2001).
12. Sharp P, Bailes E, Gao F, Beer B, Hirsch V, Hahn B. Origins and evolution of AIDS viruses: Estimating the time-scale. Biochem. Soc. Trans. 28(2), 275-282 (2000).
13. Korber B, Muldoon M, Theiler J etal. Timing the ancestor of the HIV-1 pandemic strains. Science 288(5472), 1789-1796 (2000).
14. Hu W, Temin H. Retroviral recombination and reverse transcription. Science 250(4985), 1227-1233 (1990).
15. Shriner D, Rodrigo AG, Nickle DC, Mullins JI. Pervasive genomic recombination of HIV-1 invivo. Genetics 167(4), 1573-1583 (2004).
16. Preston B, Poiesz B, Loeb L. Fidelity of HIV-1 reverse transcriptase. Science 242(4882), 1168-1171 (1988).
17. Wei X, Ghosh SK, Taylor ME etal. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373(6510), 117-122 (1995).
18. Holmes EC. On the origin and evolution of the human immunodeficiency virus (HIV). Biol. Rev. 76(2), 239-254 (2001).
19. Plantier J, Leoz M, Dickerson J etal. A new human immunodeficiency virus derived from gorillas. Nat. Med. 15(8), 871-872 (2009).
20. Robertson DL, Anderson JP, Bradac JA etal. HIV-1 nomenclature proposal. Science 288(5463), 55 (2000).
21. Ibe S, Yokomaku Y, Shiino T etal. HIV-2 CRF01-AB: First circulating recombinant form of HIV-2. J. Acquir. Immune Defic. Syndr. 54(3), 241-247 (2010). n Circulating recombinant forms also occur in HIV-2. Using phylogenetic methods, the authors demonstrated the recombinant nature of HIV-2 isolates.
22. Cheng Z, Ventura M, She X etal. A genome-wide comparison of recent chimpanzee and human segmental duplications. Nature 437(7055), 88-93 (2005).
23. Peeters M, Sharp PM. Genetic diversity of HIV-1: The moving target. AIDS 14, S129-S140 (2000).
24. Barroso H, Borrego P, Bartolo I etal. Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection. PLoS ONE 6(1), e14548 (2011).
25. Kanki PJ, Travers KU, Marlink RG etal. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343(8903), 943-946 (1994).
26. Leligdowicz A, Yindom L-M, Onyango C etal. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J. Clin. Invest. 117(10), 3067-3074 (2007).
27. Kanki PJ, Hamel DJ, Sankale JL etal. Human immunodeficiency virus type 1 subtypes differ in disease progression. J. Infect. Dis. 179(1), 68-73 (1999).
28. Tscherning C, Alaeus A, Fredriksson R etal. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241(2), 181-188 (1998).
29. Kiwanuka N, Laeyendecker O, Quinn TC etal. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 23(18), 2479-2484 (2009).
30. Abecasis AB, Lemey P, Vidal N etal. Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: Subtype G is a circulating recombinant form. J. Virol. 81(16), 8543-8551 (2007).
31. Tajima F. Evolutionary relationship of DNA-sequences in finite populations. Genetics 105(2), 437-460 (1983).
32. Nei M. Phylogenetic analysis in molecular evolutionary genetics. Annu. Rev. Genet. 30, 371-403 (1996).
33. Watterson GA. On the number of segregating sites in genetical models without recombination. Theor. Popul. Biol. 7(2), 256-276 (1975).
34. Kuhner MK. Coalescent genealogy samplers: Windows into population history. Trends Ecol. Evol. 24(2), 86-93 (2009). nn Summary of diversity and feature of current coalescent-based estimators of phylodynamic-related parameter. Good reference to compare current implementations.
35. Kuhner MK, Smith LP. Comparing likelihood and Bayesian coalescent estimation of population parameters. Genetics 175(1), 155-165 (2007).
36. Kuhner MK. Robustness of coalescent estimators to between-lineage mutation rate variation. Mol. Biol. Evol. 23(12), 2355-2360 (2006).
37. Kuhner MK, Yamato J, Felsenstein J. Estimating effective population size and mutation rate from sequence data using Metropolis-Hastings sampling. Genetics 140, 1421-1430 (1995).
38. Crandall K, Posada D, Vasco D. Effective population sizes: Missing measures and missing concepts. Anim. Conserv. 2(4), 317-319 (1999).
39. Wang J. Estimation of effective population sizes from data on genetic markers. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360(1459), 1395-1409 (2005).
40. Schwartz MK, Tallmon DA, Luikart G. Review of DNA-based census and effective population size estimators. Anim. Conserv. 1(4), 293-299 (1998).
41. Metzker ML. Sequencing technologies -the next generation. Nat. Rev. Genet. 11(1), 31-46 (2010). nn Excellent review covering next-generation sequencing technologies, their pros and cons and applications.
42. Vrancken B, Lequime S, Theys K, Lemey P. Covering all bases in HIV research: Unveiling a hidden world of viral evolution. AIDS Rev. 12(2), 89-102 (2010).
43. Zagordi O, Klein R, Daumer M, Beerenwinkel N. Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res. 38(21), 7400-7409 (2010).
44. Zagordi O, Geyrhofer L, Roth V, Beerenwinkel N. Deep sequencing of a genetically heterogeneous sample: Local haplotype reconstruction and read error correction. J. Comput. Biol. 17(3), 417-428 (2010).
45. Zagordi O, Bhattacharya A, Eriksson N, Beerenwinkel N. ShoRAH: Estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinformatics 12(1), 119 (2011). n Original description of an algorithm that can take next-generation sequencing data and return genetic diversity measures and haplotype number and frequencies using a Bayesian framework.
46. Willerth SM, Pedro HAM, Pachter L, Humeau LM, Arkin AP, Schaffer DV. Development of a low bias method for characterizing viral populations using next generation sequencing technology. PLoS ONE 5(10), e13564 (2010).
47. Henn M, Boutwell C, Lennon N etal. P09-20 LB. Ultra-deep sequencing of full-length HIV-1 genomes identifies rapid viral evolution during acute infection. Retrovirology 6(Suppl. 3), P400 (2009).
48. Fischer W, Keele B, Bhattacharya T etal. P09-21 LB. Deep sequencing of HIV-1 from acute infection: Low initial diversity, and rapid but variable CTL escape. Retrovirology 6(3), P401 (2009).
49. Poon AFY, Swenson LC, Dong WWY etal. Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1. Mol. Biol. Evol. 27(4), 819-832 (2010).
50. Redd AD, Collinson-Streng A, Martens C etal. Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda using next generation deep sequencing. J. Clin. Microbiol. 49(8), 2859-2867 (2011).
51. Castro-Nallar E, Pérez-Losada M, Burton GF, Crandall KA. The evolution of HIV: Inferences using phylogenetics. Mol. Phylogenet. Evol. 62(2), 777-792 (2012).
52. Kosakovsky Pond SL, Posada D, Stawiski E etal. An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput. Biol. 5(11), e1000581 (2009).
53. Willerth SM, Pedro HLaM, Pachter L, Humeau LM, Arkin AP, Schaffer DV. Development of a low bias method for characterizing viral populations using next generation sequencing technology. PLoS ONE 5(10), e13564 (2010).
54. Grenfell BT, Pybus OG, Gog JR etal. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303(5656), 327-332 (2004).
55. Drummond A, Ho S, Phillips M, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4(5), 699-710 (2006).
56. Thorne JL, Kishino H. Divergence time and evolutionary rate estimation with multilocus data. Syst. Biol. 51(5), 689-702 (2002).
57. Drummond A, Suchard M. Bayesian random local clocks, or one rate to rule them all. BMC Biol. 8, 114 (2010).
58. Drummond A, Rambaut A, Shapiro B, Pybus O. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 22(5), 1185-1192 (2005).
59. Lemey P, Rambaut A, Welch JJ, Suchard MA. Phylogeography takes a relaxed random walk in continuous space and time. Mol. Biol. Evol. 27(8), 1877-1885 (2010).
60. Lemey P, Rambaut A, Drummond AJ, Suchard MA. Bayesian phylogeography finds its roots. PLoS Comput. Biol. 5(9), e1000520 (2009).
61. Beerli P, Felsenstein J. Maximum likelihood estimation of a migration matrix and effective population sizes in n subpopulations by using a coalescent approach. Proc. Natl Acad. Sci. USA 98(8), 4563-4568 (2001).
62. Hey J. Isolation with migration models for more than two populations. Mol. Biol. Evol. 27(4), 905-920 (2010).
63. Shapiro B, Ho SYW, Drummond AJ, Suchard MA, Pybus OG, Rambaut A. A Bayesian phylogenetic method to estimate unknown sequence ages. Mol. Biol. Evol. 28(2), 879-887 (2011).
64. Choi S, Hey J. Joint inference of population assignment and demographic history. Genetics 189(2), 561-577 (2011).
65. Huelsenbeck JP, Andolfatto P. Inference of population structure under a Dirichlet process model. Genetics 175(4), 1787-1802 (2007).
66. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155(2), 945-959 (2000).
67. Volz EM, Pond SLK, Ward MJ, Brown AJL, Frost SDW. Phylodynamics of infectious disease epidemics. Genetics 183(4), 1421-1430 (2009). n Excellent article that deals with phylodynamic patterns and their associated processess. It also describes algorithms to integrate epidemiological and phylogenetic models.
68. Stadler T. Sampling-through-time in birth-death trees. J. Theor. Biol. 267(3), 396-404 (2010).
69. Stadler T, Kouyos R, Von Wyl V etal. Estimating the basic reproductive number from viral sequence data. Mol. Biol. Evol. 29(1), 347-357 (2012).
70. Stack JC, Welch JD, Ferrari MJ, Shapiro BU, Grenfell BT. Protocols for sampling viral sequences to study epidemic dynamics. J. R. Soc. Interface 7(48), 1119-1127 (2010).
71. de Oliveira T, Pillay D, Gifford R; the UK Collaborative Group on HIV Drug Resistance. The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS ONE 5(2), E9311 (2010).
72. Bao Y, Bolotov P, Dernovoy D etal. The influenza virus resource at the national center for biotechnology information. J. Virol. 82(2), 596-601 (2008).
73. Frost SDW, Volz EM. Viral phylodynamics and the search for an 'effective number of infections'. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365(1548), 1879-1890 (2010).
74. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. UN, Geneva, Switzerland (2010).
75. Hemelaar J, Gouws E, Ghys PD, Osmanov S; WHO-UNAIDS. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25(5), 679-689 (2011).
76. Wertheim JO, Worobey M. Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2. PLoS Comput. Biol. 5(5), e1000377 (2009).
77. Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme A-M. Tracing the origin and history of the HIV-2 epidemic. Proc. Natl Acad. Sci. USA 100(11), 6588-6592 (2003).
78. Lemey P, Pybus OG, Rambaut A etal. The molecular population genetics of HIV-1 group O. Genetics 167(3), 1059-1068 (2004).
79. Gao F, Bailes E, Robertson D etal. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397(6718), 436-441 (1999).
80. Santiago ML, Bibollet-Ruche F, Bailes E etal. Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee. J. Virol. 77(3), 2233-2242 (2003).
81. Santiago ML, Rodenburg CM, Kamenya S etal. SIVcpz in wild chimpanzees. Science 295(5554), 465 (2002).
82. Worobey M, Gemmel M, Teuwen DE etal. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455(7213), 661-664 (2008).
83. Vidal N, Peeters M, Mulanga-Kabeya C etal. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in central Africa. J. Virol. 74(22), 10498-10507 (2000).
84. Gilbert M, Rambaut A, Wlasiuk G, Spira T, Pitchenik A, Worobey M. The emergence of HIV/AIDS in the Americas and beyond. Proc. Natl Acad. Sci. USA 104(47), 18566-18570 (2007).
85. Pérez-Losada M, Jobes DV, Sinangil F, Crandall KA, Posada D, Berman PW. Phylodynamics of HIV-1 from a Phase-III AIDS vaccine trial in North America. Mol. Biol. Evol. 27(2), 417-425 (2010).
86. Robbins KE, Lemey P, Pybus OG etal. U.S. human immunodeficiency virus type 1 epidemic: Date of origin, population history, and characterization of early strains. J. Virol. 77(11), 6359-6366 (2003).
87. Rousseau CM, Learn GH, Bhattacharya T etal. Extensive intrasubtype recombination in South African human immunodeficiency virus type I subtype C infections. J. Virol. 81(9), 4492-4500 (2007).
88. Ayehunie S, Johansson B, Sonnerborg A etal. New subtype of HIV-1 in Ethiopia. Lancet 336(8720), 942 (1990).
89. Sridharan G, Kandathil AJ, Ramalingam S, Kannangai R, David S. Molecular epidemiology of HIV. Indian J. Med. Res. 121(4), 333-344 (2005).
90. Shankarappa R, Gupta P, Chatterjee R etal. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: Identification of features that distinguish subtype C sequences in India from other subtype C sequences. J. Virol. 75(21), 10479-10487 (2001).
91. Fontella R, Schrago C, Soares M. On the origin of HIV-1 subtype C in South America. AIDS 22(15), 2001-2011 (2008).
92. Bello G, Passaes C, Guimaraes ML etal. Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS 22(15), 1993-2000 (2008).
93. Deng X, Yang R, Liu H, Shao Y, Rayner S. Theepidemic origin and molecular properties of B́: A founder strain of the HIV-1 transmission in Asia. AIDS 22(14), 1851-1858 (2008).
94. Piyasirisilp S, Mccutchan FE, Carr JK etal. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J. Virol. 74(23), 11286-11295 (2000).
95. De Silva U, Warachit J, Sattagowit N etal. Genotypic characterization of HIV type 1 env gp160 sequences from three regions in Thailand. AIDS Res. Hum. Retrov. 26(2), 223-227 (2010).
96. Su L, Graf M, Zhang YZ etal. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B́) recombinant strain in China. J. Virol. 74(23), 11367-11376 (2000).
97. Skar H, Hedskog C, Albert J. HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance. Ann. NY Acad. Sci. 1230, 108-118 (2011).
98. Hué S, Pillay D, Clewley JP, Pybus OG. Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc. Natl Acad. Sci. USA 102(12), 4425-4429 (2005). n Phylodynamic study that attempts to untangle the complex structure of HIV in populations of men who have sex with men in the UK. It shows that HIV has been introduced into that population severaltimes.
99. Zehender G, Ebranati E, Lai A etal. Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy. J. Acquir. Immune Defic. Syndr. 55, 156-160 (2010).
100. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Brown AJL. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med. 5(3), 392-402 (2008).
101. Liao HA, Tee KK, Hase S etal. Phylodynamic analysis of the dissemination of HIV-1 CRF01-AE in Vietnam. Virology 391(1), 51-56 (2009).
102. Leitner T, Escanilla D, Franzén C, Uhlénn M, Albert J. Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc. Natl Acad. Sci. USA 93(20), 10864-10869 (1996).
103. Lemey P, Derdelinckx I, Rambaut A etal. Molecular footprint of drug-selective pressure in a human immunodeficiency virus transmission chain. J. Virol. 79(18), 11981-11989 (2005).
104. Ou C-Y, Ciesielski CA, Myers G etal. Molecular epidemiology of HIV transmission in a dental practice. Science 256(5060), 1165-1171 (1992).
105. Albert J, Wahlberg J, Leitner T, Escanilla D, Uhlen M. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J. Virol. 68(9), 5918-5924 (1994).
106. Holmes EC, Zhang LQ, Simmonds P, Rogers AS, Brown AJL. Molecular investigation of human-immunodeficiency-virus (HIV) infection in a patient of an HIV-infected surgeon. J. Infect. Dis. 167(6), 1411-1414 (1993).
107. Metzker ML, Mindell DP, Liu XM, Ptak RG, Gibbs RA, Hillis DM. Molecular evidence of HIV-1 transmission in a criminal case. Proc. Natl Acad. Sci. USA 99(22), 14292-14297 (2002).
108. Bernard E, Azad Y, Vandamme A, Weait M, Geretti A. HIV forensics: Pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission. HIV Med. 8(6), 382-387 (2007).
109. Edwards C, Holmes E, Wilson D etal. Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1. BMC Evol. Biol. 6, 28 (2006). n Relevant study showing the loss of GD across vertical and horizontal transmissions. It also illustrates the use of phylodynamic approaches to answer clinically important questions.
110. Salazar-González JF, Bailes E, Pham KT etal. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82(8), 3952-3970 (2008).
111. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. The genomic and epidemiological dynamics of human influenza A virus. Nature 453(7195), 615-619 (2008).
112. Brown AJL. Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc. Natl Acad. Sci. USA 94(5), 1862-1865 (1997).
113. Crandall KA, Kelsey CR, Imamichi H, Lane HC, Salzman NP. Parallel evolution of drug resistance in HIV: Failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol. Biol. Evol. 16(3), 372-382 (1999).
114. Carvajal-Rodríguez A, Crandall K, Posada D. Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy. Infect. Genet. Evol. 7(4), 476-483 (2007).
115. Salemi M, Lamers SL, Yu S, De Oliveira T, Fitch WM, McGrath MS. Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J. Virol. 79(17), 11343-11352 (2005).
116. Salemi M, Burkhardt BR, Gray RR, Ghaffari G, Sleasman JW, Goodenow MM. Phylodynamics of HIV-1 in lymphoid and non-lymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispecies. PLoS ONE 2(9), e950 (2007).
117. Salemi M, Lamers SL, Huysentruyt LC etal. Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-hodgkins lymphoma. PLoS ONE 4(12), e8153 (2009).
118. Potter SJ, Lemey P, Achaz G etal. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J. Leukoc. Biol. 76(3), 562-570 (2004).
119. Potter SJ, Lemey P, Dyer WB etal. Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART. Virology 348(1), 35-46 (2006).
120. Pearse DE, Crandall KA. Beyond FST: Analysis of population genetic data for conservation. Conserv. Genet. 5(5), 585-602 (2004).
121. Hubisz MJ, Falush D, Stephens M, Pritchard JK. Inferring weak population structure with the assistance of sample group information. Mol. Ecol. Resour. 9(5), 1322-1332 (2009).
122. Huelsenbeck JP, Andolfatto P, Huelsenbeck ET. Structurama: Bayesian inference of population structure. Evol. Bioinform. 7, 55-59 (2011).
123. Shringarpure S, Won D, Xing EP. StructHDP: Automatic inference of number of clusters and population structure from admixed genotype data. Bioinformatics 27(13), i324-i332 (2011).
124. Shankarappa R, Margolick JB, Gange SJ etal. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73(12), 10489-10502 (1999).
125. Lee HY, Perelson AS, Park SC, Leitner T. Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression. PLoS Comput. Biol. 4(12), e1000240 (2008).
126. Llibre JM, Schapiro JM, Clotet B. Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV-1-infected patients with virological failure. Clin. Infect. Dis. 50(6), 872-881 (2010).
127. Van Laethem K, De Munter P, Schrooten Y etal. No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: Impact of resistant minority variants on efficacy of low genetic barrier drugs. J. Clin. Virol. 39(1), 43-47 (2007).
128. Pingen M, Nijhuis M, De Bruijn JA, Boucher CAB, Wensing AMJ. Evolutionary pathways of transmitted drug-resistant HIV-1. J. Antimicrob. Chemother. 66(7), 1467-1480 (2011).
129. Lataillade M, Chiarella J, Yang R etal. Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naive subjects in the CASTLE study. PLoS ONE 5(6), e10952 (2010).
130. Wensing AM, Van De Vijver DA, Angarano G etal. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. J. Infect. Dis. 192(6), 958-966 (2005).
131. Burgers WA, Shephard E, Monroe JE etal. Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C. AIDS Res. Hum. Retroviruses 24(2), 195-206 (2008).
132. Chen Z, Huang Y, Zhao X, Ba L, Zhang W, Ho DD. Design, construction, and characterization of a multigenic modified vaccinia Ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B́. J. Acquir. Immune Defic. Syndr. 47(4), 412-421 (2008).
133. Korber BT, Letvin NL, Haynes BF. T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces. J. Virol. 83(17), 8300-8314 (2009). nn Excellent review covering novel approaches to vaccine design and their known performances. It summarizes novel attempts to cope with HIV GD in the design of vaccines.
134. Korber B, Gnanakaran S. The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility. Curr. Opin. HIV AIDS 4(5), 408-417 (2009).
135. Rolland M, Jensen MA, Nickle DC etal. Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins. J. Virol. 81(16), 8507-8514 (2007).
136. Sodora DL, Allan JS, Apetrei C etal. Toward an AIDS vaccine: Lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat. Med. 15(8), 861-865 (2009).
137. Nakayama D, Misumi S, Mukai R etal. Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy. J. Biochem. 138(5), 571-582 (2005).
138. Misumi S, Nakayama D, Kusaba M etal. Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challenge. J. Immunol. 176(1), 463-471 (2006).
139. Wu X, Zhou T, Zhu J etal. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333(6049), 1593-1602 (2011).
140. Scheid JF, Mouquet H, Ueberheide B etal. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333(6049), 1633-1637 (2011).
141. Schadt EE, Turner S, Kasarskis A. A window into third-generation sequencing. Hum. Mol. Genet. 19(R2), R227-R240 (2010).
142. Smit C, Van Den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: A 20-year prospective study. J. Acquir. Immune Defic. Syndr. 47(2), 221-225 (2008).
143. Chen T-Y, Ding EL, Seage GR, Kim AY. Meta-analysis: Increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin. Infect. Dis. 49(10), 1605-1615 (2009).
144. Van De Laar TJ, Matthews GV, Prins M, Danta M. Acute hepatitis C in HIV-infected men who have sex with men: An emerging sexually transmitted infection. AIDS 24(12), 1799-1812 (2010).
145. Beerli P, Palczewski M. Unified framework to evaluate panmixia and migration direction among multiple sampling locations. Genetics 185(1), 313-326 (2010).
146. Drummond A, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7(1), 214 (2007).
147. Kuhner MK. LAMARC 2.0: Maximum likelihood and Bayesian estimation of population parameters. Bioinformatics 22(6), 768-770 (2006).
148. Auton A, Mcvean G. Recombination rate estimation in the presence of hotspots. Genome Res. 17(8), 1219-1227 (2007).
149. Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P. RDP3: A flexible and fast computer program for analyzing recombination. Bioinformatics 26(19), 2462-2463 (2010).
150. Pond SLK, Frost SDW, Muse SV. HyPhy: Hypothesis testing using phylogenies. Bioinformatics 21(5), 676-679 (2005).
151. Suzuki Y, Gojobori T, Nei M. ADAPTSITE: Detecting natural selection at single amino acid sites. Bioinformatics 17(7), 660-661 (2001).
152. Woolley S, Johnson J, Smith MJ, Crandall KA, Mcclellan DA. TreeSAAP: Selection on amino acid properties using phylogenetic trees. Bioinformatics 19(5), 671-672 (2003).
153. Maddison W, Maddison D. Mesquite: A modular system for evolutionary analysis. Evolution 62, 1103-1118 (2005).